Greg had been told for three years that his blood work was “completely normal.” His TSH was 3.8 mIU/L — within the standard lab range of 0.5-4.5. His ferritin was 18 ng/mL — within the standard lab range of 12-300. His vitamin D was 32 ng/mL — within the standard lab range of 30-100. Meanwhile he was dealing with significant fatigue, brain fog, cold intolerance, hair loss, and a general decline in the quality of his life. Three different primary care physicians looked at his numbers and told him he was fine. The problem wasn’t negligence on any of their parts — it was that the lab reference ranges they were using had been built on populations that included a substantial share of sick people, and “within the range where most people fall” is not the same thing as “where you’ll feel and function optimally.” Greg needed different numbers to evaluate his numbers against.
This is a systematic guide to the gap between normal and optimal — what it means for the key biomarkers, why the gap exists in the first place, and what numbers actually deserve targeting.
How Lab Reference Ranges Are Established
Understanding why standard lab ranges fall short for health optimization starts with understanding how those ranges got built. Most reference intervals are established statistically — they capture the values containing the middle 95% of a presumably “normal” reference population. Anything outside the 2.5th or 97.5th percentile gets flagged “abnormal.”
The problems compound and interconnect. First: the reference population includes sick people. In the United States, where metabolic dysfunction, subclinical thyroid disease, insulin resistance, and nutritional deficiencies run extraordinarily prevalent, that reference population isn’t a healthy baseline — it’s a population average that includes a lot of undiagnosed conditions. If 40% of the reference population has subclinical hypothyroidism, the “normal” TSH range will encompass hypothyroid levels. And when the reference population is drawn from patients attending a standard medical clinic — which many lab reference populations are — the comparison group already skews sick.
Second: reference ranges are population averages, not optimal targets. The 95% interval tells you where 95% of people fall. It says nothing about where people feel best, function optimally, or carry the lowest long-term health risk. Sitting in the top quartile of the “normal” TSH range — technically not flagged as abnormal — is meaningfully different from sitting in the optimal quarter for thyroid function.
Third: the ranges exist to identify disease, not optimize health. Labs are built for clinical diagnosis — catching when someone has a condition requiring treatment. They were never built to answer “am I at the level where I’ll function best?” Those are genuinely different questions with genuinely different answers, and failing to separate them is responsible for more preventable suffering than almost any other gap in conventional medicine.
Medicine was designed to treat disease in sick people. When you walk into a lab, you’re being evaluated against a population of other people, many of whom are also unwell. “You look normal compared to this group” is useful information if you’re trying not to be hospitalized. It’s insufficient information if you’re trying to feel and function at your best.
A 2014 review by Wahls and colleagues, drawing the distinction between laboratory normal ranges and functional optimal ranges, has become influential in functional medicine circles — though the optimal-range debate is ongoing and varies somewhat by practitioner philosophy. The core insight, that “not diseased” and “optimally healthy” are different standards, is broadly supported by the research even where the specific optimal cutoffs are still being refined.
TSH: The Thyroid Hormone Marker Misread Most Often
Thyroid stimulating hormone (TSH) is the pituitary’s signal to the thyroid gland — it tells the thyroid to produce more thyroid hormone. High TSH means the pituitary is shouting at an underperforming thyroid (hypothyroidism). Low TSH means it’s backing off from an overperforming one (hyperthyroidism).
The standard lab range for TSH is typically 0.5-4.5 mIU/L, with some labs using 0.4-4.0 or a slight variant. Most people with TSH above 2.5 get told their thyroid is “normal.” The evidence suggests otherwise, and this is one of the more consequential interpretive gaps in modern medicine.
Research by Biondi and Cooper, published in the New England Journal of Medicine in 2012, along with multiple later stud
| Marker | Standard “Normal” Range | Research-Based Optimal |
|---|---|---|
| TSH | 0.5-4.5 mIU/L | 1.0-2.0 mIU/L |
| Ferritin (men) | 12-300 ng/mL | ~40-100 ng/mL |
| HbA1c | Below 5.7% (pre-diabetes threshold) | Below 5.3% |
ies, found TSH above 2.0-2.5 mIU/L associated with higher rates of subclinical hypothyroidism symptoms, higher cardiovascular risk, and worse lipid profiles — even in people who stay within the “normal” range. A large study by Rodondi and colleagues in JAMA in 2010 found that even high-normal TSH within the reference range carried elevated cardiovascular disease risk. Not fringe findings. These appear in the flagship journals of mainstream medicine.
The American Thyroid Association’s 2012 guidelines acknowledged the controversy over TSH reference ranges, with some experts arguing the upper limit should sit at 2.5 mIU/L rather than 4.5. A 2002 paper by Wartofsky and Dickey in the Journal of Clinical Endocrinology and Metabolism, using a reference population rigorously screened to exclude people with thyroid antibodies and family history of thyroid disease, found the genuinely healthy population range was 0.4-2.5 mIU/L. The debate continues, but the functional medicine consensus has largely settled on a TSH optimal range of 1.0-2.0 mIU/L as the zone where thyroid function and associated outcomes are best.
Greg’s TSH of 3.8 mIU/L? Technically “normal” by standard lab criteria. Functionally, it sits in a range where multiple studies have found elevated symptom burden and cardiovascular risk. His symptoms — fatigue, cold intolerance, hair loss, brain fog — matched subclinical hypothyroidism. The lab range said normal. The research said otherwise. And a comprehensive thyroid panel (free T3, free T4, reverse T3, anti-TPO, anti-thyroglobulin antibodies) eventually surfaced what the TSH alone was hiding: active autoimmune thyroid destruction.
Ferritin: The Iron Storage Marker with a Useless Reference Range
Ferritin is a protein that stores iron — serum ferritin is the primary marker for body iron stores. The standard lab range for ferritin is enormous: roughly 12-300 ng/mL for men, 12-150 ng/mL for women (varies somewhat by lab). A 25-fold range in men. Wide enough to span everything from iron depletion to iron overload with no meaningful differentiation in between. If a reference range runs 25 times wider than its own minimum, it’s not a clinically useful range for health optimization. It’s a floor low enough to catch severe deficiency and a ceiling high enough to avoid flagging early iron overload.
The critical insight: ferritin below 40-50 ng/mL is associated with iron deficiency symptoms even when it sits above the lab’s flagged-low threshold of 12 ng/mL. Research by Bjorn-Rasmussen and colleagues, along with later work on iron and cognitive function, has found fatigue, cognitive impairment, reduced exercise tolerance, and hair loss beginning well above the clinical anemia threshold. The body preferentially maintains hemoglobin at the expense of ferritin — someone can be iron-depleted in terms of stores while hemoglobin sits comfortably in the normal range, which is exactly why ferritin testing matters even when the complete blood count looks fine.
A landmark 2003 study by Verdon and colleagues in the British Medical Journal specifically examined women with fatigue and ferritin below 50 ng/mL but hemoglobin above the anemia threshold — technically “normal” by standard criteria. Iron supplementation significantly reduced fatigue compared to placebo, demonstrating that functional iron deficiency exists at ferritin levels labs classify as normal. Not an obscure study. Cited in thousands of subsequent papers. And yet the standard lab range remains unchanged, and millions of people with ferritin of 18 keep getting told their iron is fine.
The optimal range for ferritin depends somewhat on context: for basic daily function, 40-100 ng/mL is where most adults report optimal energy and cognitive function. For athletes with high iron turnover from training-related red blood cell destruction, 70-150 ng/mL may fit better. Above 150-200 ng/mL in women or 200-300 ng/mL in men (outside hereditary hemochromatosis and active inflammatory disease), ferritin stops providing additional functional benefit. Ferritin above 300 in men or 200 in women without a clear clinical explanation — chronic inflammation, liver disease — warrants investigation for iron overload conditions including hereditary hemochromatosis.
Greg’s ferritin of 18 ng/mL? Above the lab’s “low” threshold of 12, so unflagged. But 18 sits well below the functional optimal of 40-100, and multiple studies would predict exactly the fatigue and brain fog he was living with. The lab said normal. The research said functional iron deficiency. Treatment — iron supplementation with attention to absorption, taken with vitamin C, away from calcium and coffee — resolved his fatigue substantially within twelve weeks.
Vitamin D: The Difference Between Not Deficient and Actually Optimal
The vitamin D reference range debate is probably the most contentious in functional medicine, largely because vitamin D functions as a hormone rather than a plain nutrient, with receptors in virtually every tissue in the body. Standard labs flag deficiency below 20-30 ng/mL depending on the lab, with most defining “sufficient” as 30-100 ng/mL. The research on optimal vitamin D function tells a more detailed story.
A comprehensive meta-analysis by Autier and colleagues, published in the Lancet Diabetes and Endocrinology in 2014, and subsequent work, has consistently found associations between vitamin D levels and health outcomes — immune function, cardiovascular disease, cancer incidence, cognitive function, muscular function — plateauing and peaking in the 40-60 ng/mL range, with diminishing or absent additional benefit above 60 ng/mL and some evidence of adverse effects above 80-100 ng/mL. Meanwhile levels of 30-39 ng/mL — technically “sufficient” by standard lab criteria — show meaningfully worse outcomes than levels of 40-60 ng/mL. The lab range calls 32 ng/mL “normal.” The research calls it suboptimal for immune function, bone density, muscle function, and probably several other outcomes besides.
The mechanisms are clear. Vitamin D receptors sit in virtually every tissue in the body, including immune cells (T and B lymphocytes, macrophages, dendritic cells), cardiac muscle, brain tissue, intestinal epithelium, and reproductive organs. Vitamin D functions as a pleiotropic nuclear hormone receptor ligand, not just a calcium regulation agent. The immune regulation function alone — its role suppressing inflammatory cytokine production, promoting regulatory T cell development, and providing innate antimicrobial defense through cathelicidin induction — makes suboptimal vitamin D status clinically significant even in people without rickets or osteomalacia.
The optimal range for maintaining adequate vitamin D-mediated gene expression across all receptor-bearing tissues appears to be 40-60 ng/mL based on the available research. Getting there typically requires supplementation for most people in northern latitudes or with indoor lifestyles. How much it takes varies substantially by body weight, skin tone, age, and baseline level, which is why the retest at 8-12 weeks is the part that actually matters — a baseline of 32 climbing into the low 40s is the kind of movement that represents meaningful optimization. Vitamin K2 as MK-7 belongs alongside the D3, to direct the calcium that vitamin D helps absorb toward bone rather than arteries.
Fasting Insulin: The Metabolic Marker Most Labs Don’t Run
One of the most informative metabolic markers — fasting insulin — isn’t included in standard blood work most physicians order. A significant gap, because fasting insulin gives early warning of insulin resistance years to decades before fasting glucose or HbA1c go abnormal. Arguably the single most important marker missing from standard preventive care.
The mechanism: when cells go insulin resistant, the pancreas compensates by producing more insulin to drive the same glucose into cells. Fasting insulin rises — sometimes dramatically — before glucose does, because that compensatory hyperinsulinemia is actively preventing the glucose elevation. By the time fasting glucose or HbA1c go abnormal — the standard diagnostic criteria for pre-diabetes and diabetes — insulin resistance has typically been present for 5-15 years.
Years during which the condition kept worsening, cardiovascular damage kept accumulating, and elevated fasting insulin was the signal nobody was checking.
The standard reference range for fasting insulin is typically 2-19 μIU/mL or similarly wide. The functional optimal — the level tied to lowest cardiovascular risk, best metabolic function, lowest long-term diabetes risk — sits below 5-7 μIU/mL. Research by Reaven and colleagues, and later metabolic studies, have shown fasting insulin above 10-15 μIU/mL associated with dramatically elevated cardiovascular disease risk, even in people with “normal” blood sugar by standard criteria. HOMA-IR (fasting insulin in μIU/mL times fasting glucose in mmol/L, divided by 22.5) gives a standardized measure of insulin resistance; values above 2.0-2.5 carry significantly elevated metabolic disease risk regardless of fasting glucose.
Adding fasting insulin to standard blood work is cheap — typically $15-30 as a standalone test at direct-access labs — and buys a decade of advance warning on metabolic trajectory. That it’s not routinely ordered says a lot about standard medicine’s disease-detection orientation versus health-optimization. A physician’s job, as currently structured, is catching diabetes once it’s there. Optimal range medicine’s job is catching insulin resistance before it becomes diabetes.
HbA1c: The Blood Sugar Average with a Misleading Threshold
Hemoglobin A1c measures the three-month average blood glucose through glycation of hemoglobin. The conventional thresholds — 5.7% for pre-diabetes, 6.5% for diabetes — are built to identify established disease and pre-disease. The optimal range for longevity and metabolic health, based on population-level outcome data, runs tighter.
Multiple large epidemiological studies have found cardiovascular risk rising continuously with HbA1c well below the pre-diabetes threshold of 5.7%. A 2014 analysis of NHANES data found HbA1c in the 5.4-5.6% range — technically “normal,” well below the pre-diabetes threshold — associated with meaningfully elevated cardiovascular disease and all-cause mortality risk compared to HbA1c below 5.0-5.2%. The relationship is continuous, not threshold-based. There’s no magic line at 5.7% below which glycemic risk vanishes.
The functional optimal target for HbA1c is below 5.3%, with 4.8-5.2% ideal. Not a treatment target recognized in conventional guidelines, which appropriately focus on population-level interventions and treatment thresholds. But for individual health optimization — finding the lowest glycemic average tied to minimal long-term cardiovascular, cognitive, and renal risk — the evidence consistently points to sub-5.3% as meaningfully better than the 5.5-5.6% range conventional medicine dismisses as “excellent.”
High-Sensitivity CRP: Finding the Inflammation Before It Finds You
High-sensitivity C-reactive protein (hs-CRP) is the most widely available, validated marker of systemic inflammation relevant to cardiovascular risk. Standard CRP tests are built for detecting acute inflammatory disease — infections, autoimmune flares — and aren’t sensitive enough for cardiovascular risk stratification. High-sensitivity CRP measures the same protein at concentrations relevant to chronic low-grade inflammation.
The JUPITER trial — a landmark randomized controlled trial of 17,802 patients published in the New England Journal of Medicine in 2008 — found people with normal LDL but elevated hs-CRP (above 2 mg/L) carrying significantly elevated cardiovascular risk, and that statin therapy reduced cardiovascular events by 44% and all-cause mortality by 20% in this population. This established vascular inflammation as a treatment target independent of LDL elevation and independent of standard risk factors. Inflammation isn’t just a risk marker. It’s a causal mechanism in atherosclerosis.
The optimal hs-CRP interpretation for cardiovascular risk: below 1.0 mg/L is low-risk. 1.0-3.0 mg/L is intermediate. Above 3.0 mg/L is high risk from an inflammatory standpoint. Many standard labs only flag hs-CRP above 5-10 mg/L — a threshold built for acute inflammatory disease, not cardiovascular risk stratification. A patient with hs-CRP of 2.8 mg/L gets told their inflammatory marker is normal; by cardiovascular risk standards they’re already in the high-risk category requiring intervention. Interventions that effectively lower hs-CRP: smoking cessation (the single most powerful one), exercise, weight loss, a Mediterranean dietary pattern, fish oil supplementation, and treating underlying inflammatory drivers — sleep apnea, dental disease, gut dysbiosis.
Homocysteine: The Cardiovascular Biomarker Your Doctor Doesn’t Order
Homocysteine is a sulfur-containing amino acid produced as an intermediate in methionine metabolism. Elevated homocysteine is an independent cardiovascular risk factor — multiple meta-analyses suggest a 25-30% increase in cardiovascular disease risk and 40-60% increase in stroke risk per 5 μmol/L rise above normal.
The mechanism is multifactorial: elevated homocysteine produces endothelial dysfunction through oxidative stress and direct cytotoxic effects on arterial endothelium; it promotes LDL oxidation into its atherogenic modified form; it impairs nitric oxide production, critical for arterial vasodilation; and it has prothrombotic effects through platelet aggregation and the coagulation cascade. Homocysteine elevation is a systemic vascular toxin whose reach extends across coronary, cerebrovascular, and peripheral vascular beds.
The applicable insight: elevated homocysteine is almost entirely correctable with B vitamin supplementation. Homocysteine metabolism requires three B vitamin cofactors — B12 (for methionine synthase), folate (for methylenetetrahydrofolate reductase), and B6 (for cystathionine beta-synthase). Deficiency or insufficiency in any of the three elevates homocysteine. The MTHFR C677T polymorphism — present in roughly 10% of the population in homozygous form, 35-40% heterozygous — reduces MTHFR activity by 30-65%, impairing folate metabolism and elevating homocysteine even with adequate folate intake. Testing for MTHFR and using the appropriate methylated B vitamins (methylfolate, methylcobalamin) addresses this genetic variant directly.
Target homocysteine: below 10 μmol/L by standard criteria, below 8 μmol/L by optimal range criteria. The intervention targets the two pathways that clear homocysteine, which is why it runs on methylfolate, methylcobalamin and B6 together rather than on any one of them. Retest at 8-12 weeks to confirm response. One of the most straightforward and inexpensive nutritional interventions with clear cardiovascular payoff — and routinely not ordered or addressed in standard care.
Magnesium: The Deficiency That Standard Testing Systematically Misses
Magnesium participates in over 300 enzymatic reactions — ATP synthesis, protein synthesis, DNA repair, muscle contraction and relaxation, NMDA receptor modulation, insulin receptor signaling. One of the most important minerals in human physiology, and simultaneously one of the most commonly deficient in Western populations, with estimates suggesting 50-70% of Americans fall short of the RDA through diet alone.
Here’s the testing problem: standard serum magnesium is a poor indicator of total body magnesium status. Serum magnesium represents less than 1% of total body magnesium — the vast majority sits intracellular, in bone, and in soft tissue. The kidney holds serum magnesium within a narrow range even as intracellular stores get depleted, drawing from bone and muscle reserves to do it. Someone can have serum magnesium sitting comfortably in the “normal” range of 0.75-1.0 mmol/L while their cells run severely magnesium-depleted. Serum magnesium only turns abnormal in severe deficiency, by which point symptoms are significant and have often been present for years.
RBC (red blood cell) magnesium is a substantially better measure of functional intracellular magnesium status. Red blood cells concentrate magnesium from plasma over their 120-day lifespan, giving a medium-term average of cellular magnesium availability. Optimal RBC magnesium: 5.5-7.5 mg/dL. Many labs’ reference ranges extend down to 4.0 mg/dL — meaningfully below the cellular optimum for the enzyme systems that need this mineral.
Symptoms of functional magnesium insufficiency (RBC magnesium sitting low-normal to insufficient): muscle cramps and spasms, headaches (magnesium deficiency is a major modifiable headache trigger), anxiety and difficulty sleeping (magnesium modulates GABA receptors and NMDA activity), constipation (magnesium is required for smooth muscle relaxation throughout the GI tract), palpitations (magnesium is a natural calcium channel modulator in cardiac tissue), and fatigue from impaired ATP synthesis.
Supplementation: magnesium glycinate or magnesium malate give the best absorption with minimal GI side effects (magnesium oxide absorbs poorly and turns laxative at the doses needed for repletion). Read the elemental magnesium figure rather than the compound weight — glycinate is a heavy molecule and the two numbers are far apart. Blood pressure medications, proton pump inhibitors, and high alcohol intake all deplete magnesium, so repletion is a slower job in those situations.
The Optimal Range Reference Guide: Key Biomarkers
This framework lays out functional optimal ranges for key biomarkers, contrasted against standard lab ranges. These optimal ranges draw on research literature about where outcomes are best, not on where 95% of a mixed-health population happens to fall. Use them as targets for optimization, not just as flags for pathology. They aren’t diagnostic criteria — they’re navigation tools for health optimization, applied alongside appropriate clinical evaluation.
TSH (Thyroid Stimulating Hormone):
Lab range 0.5-4.5 mIU/L. Optimal: 1.0-2.0 mIU/L. TSH above 2.5 warrants further thyroid evaluation (comprehensive panel including fT3, fT4, reverse T3, anti-TPO antibodies, anti-thyroglobulin antibodies) even if technically “normal.” Context: morning fasting, not on biotin supplements (biotin interferes with many thyroid assays).
Ferritin: Lab range 12-300 ng/mL (men). Optimal: 70-150 ng/mL (men); 40-100 ng/mL (women). Below 40 in either sex = functional iron insufficiency even without anemia. Above 200 in women or 300 in men without active inflammation warrants investigation for iron overload. Context: ferritin is an acute phase reactant — elevated ferritin alongside elevated CRP may reflect inflammation rather than iron overload.
Vitamin D (25-OH D3):
Lab range 30-100 ng/mL (“sufficient”). Optimal: 40-60 ng/mL. Below 30 = true deficiency. 30-39 = insufficient for optimal immune and musculoskeletal function. Above 80 = watch for adverse effects including hypercalcemia and hypercalciuria, particularly with supplementation without K2. Context: measure at the lowest-sunlight point of the year for an accurate baseline.
Fasting Insulin:
Lab range 2-19 μIU/mL. Optimal: below 5 μIU/mL. 5-10 = early insulin resistance signal. Above 10 = clinically significant insulin resistance. Above 15 = significant, requiring dietary and lifestyle intervention. HOMA-IR below 1.5 is optimal; 1.5-2.0 is borderline; above 2.5 is insulin resistant. Context: must be truly fasting (10+ hours), no exercise immediately before the draw.
HbA1c:
Lab range flagged at 5.7% (prediabetes) and 6.5% (diabetes). Optimal: below 5.3%. The 5.4-5.6% range — technically “normal” — correlates with significantly elevated cardiovascular risk in multiple large studies. Ideal is 4.8-5.2%. Context: HbA1c can be falsely low in people with higher red blood cell turnover (hemolytic anemia, certain genetic variants); continuous glucose monitoring gives more information than a single HbA1c reading.
- hs-CRP (High-sensitivity C-Reactive Protein): Lab range varies; most flag above 5-10 mg/L for acute inflammation. Optimal for cardiovascular risk: below 1.0 mg/L. 1-3 mg/L = moderate cardiovascular risk requiring investigation. Above 3 mg/L = high risk requiring investigation and intervention. Context: must exclude acute illness (hs-CRP acutely elevated with any infection or inflammatory flare); repeat at baseline health if acutely ill.
- Homocysteine: Lab range varies; most flag above 15 μmol/L. Optimal: below 8 μmol/L. 8-12 = suboptimal, associated with elevated cardiovascular risk. Above 12 = clinically elevated, requiring B vitamin investigation and supplementation. Context: fasting for 4+ hours, as homocysteine rises postprandially.
- Total Testosterone (men): Lab range roughly 300-1000 ng/dL. Functional optimal: 550-900 ng/dL. Men in the 300-500 range — technically “normal” — often experience symptoms of hypogonadism that resolve once levels are optimized. Free testosterone (calculated) optimal: above 15 ng/dL or above 75 pg/mL (lab unit varies). Context: morning fasting draw, 7-10 AM; results aren’t valid for clinical decisions if drawn in the afternoon.
- RBC Magnesium: Lab range varies by lab; approximately 4.0-6.4 mg/dL. Optimal: 5.5-7.5 mg/dL. Values in the 4.0-5.5 range — technically “normal” by some lab ranges — sit below optimal for the enzyme systems requiring intracellular magnesium. Context: standard serum magnesium is not a useful measure of tissue magnesium status; specifically request RBC magnesium.
Cholesterol and Lipids: Why LDL-C Is the Wrong Marker
The standard lipid panel reports LDL cholesterol — the concentration of cholesterol carried in LDL particles. Calculated, not measured directly, using the Friedewald equation in most labs. The fundamental problem: LDL particle number (LDL-P) and apolipoprotein B (ApoB, one per atherogenic particle) are substantially better predictors of cardiovascular risk than LDL-C. The MESA study — a large prospective cohort of 6,814 participants — found LDL-P significantly superior to LDL-C for predicting cardiovascular events.
The discordance between LDL-C and LDL-P isn’t rare: roughly 20-30% of individuals carry meaningfully different cardiovascular risk based on LDL-P than their LDL-C would suggest. Most commonly, people with metabolic syndrome and high triglycerides carry many small, dense LDL particles with low cholesterol content each — their LDL-C looks “normal” while their LDL-P runs elevated and their cardiovascular risk sits substantially higher than LDL-C would predict.
ApoB (one molecule per atherogenic particle, capturing all LDL, VLDL, IDL, and Lp(a) particles) is increasingly recommended as the primary lipid risk marker in major European cardiology guidelines. Optimal ApoB: below 80 mg/dL for primary prevention, below 65 mg/dL for secondary prevention. This single test, added to or replacing the calculated LDL-C, delivers more accurate cardiovascular risk information than the entire standard lipid panel.
Lipoprotein(a) — Lp(a) — is genetically determined, unmoved by diet or standard lipid-lowering therapy, and affects roughly 20% of the population at clinically elevated levels. It’s not in standard lipid panels. Lp(a) above 50 mg/dL (125 nmol/L) roughly doubles cardiovascular risk; above 150 nmol/L, risk runs 3-4 times elevated. Everyone should have Lp(a) measured at least once, and anyone with family history of early cardiovascular disease or unexplained elevated cardiovascular risk should get it measured as a priority.
Vitamin B12: When Normal Serum Levels Mask Functional Deficiency
Vitamin B12 (cobalamin) is essential for neurological function, red blood cell formation, and DNA synthesis. B12 deficiency causes neurological damage that can be permanent if untreated — peripheral neuropathy, subacute combined degeneration of the spinal cord, cognitive decline, and psychiatric manifestations including depression and psychosis. The standard lab range for serum B12 is typically 200-900 pg/mL; functional optimal sits above 500 pg/mL — yet patients with B12 in the 200-500 range are routinely told their B12 is normal.
The problem with serum B12 as a marker: serum cobalamin measures total B12 in circulation, including the inactive forms bound to haptocorrin proteins. Someone can have “normal” or even “high” serum B12 from elevated haptocorrin-bound inactive B12 analogues while their active B12 (transcobalamin-II-bound), the form actually available for cellular use, is severely depleted. Particularly common in people consuming fortified foods high in cyanocobalamin, or with elevated haptocorrin from other causes.
The functional markers for B12 status: methylmalonic acid (MMA) rises when adenosylcobalamin runs insufficient for the MMA-to-succinyl-CoA conversion. Elevated MMA is the most sensitive marker for functional B12 deficiency — it rises before serum B12 falls and before neurological symptoms show up. Homocysteine elevation (elevated when methionine synthase, which requires methylcobalamin, is insufficient) is less specific but complementary. A patient with serum B12 of 350 pg/mL (technically “normal”) but elevated MMA has functional B12 deficiency requiring treatment — a pattern the serum test alone would completely miss.
Taking Your Own Results Further: Practical Application
Standard medical practice orients toward identifying disease and delivering standard-of-care treatment. The optimal range framework orients toward health optimization — identifying the gradient between “not sick” and “functioning at your best” and moving toward the high end. Using both frameworks together — not replacing clinical care, but adding a higher-resolution lens to it — produces the most meaningful results.
Using this framework means either finding a physician oriented toward functional or preventive medicine, or taking responsibility for understanding your own results and having informed conversations with standard practitioners. Neither is effortless. Working with a functional medicine physician — who’ll order the comprehensive panels and interpret them against optimal rather than standard ranges — is the thorough route. Direct-to-consumer lab services (Ulta Lab Tests, LabCorp Direct, Function Health, and similar platforms) allow self-ordering of most labs, and results can be interpreted using the optimal ranges in this framework.
The practical sequence: get a comprehensive panel including the standard markers a physician orders plus fasting insulin, hs-CRP, homocysteine, a comprehensive thyroid panel (if any symptoms), RBC magnesium, vitamin D 25-OH, and ferritin. Review the results against both the lab reference ranges and the optimal ranges here. Flag any markers “within range” but below optimal. Prioritize the gaps carrying the most symptoms or risk factors. Work on one or two gaps at a time with appropriate intervention — dietary change, supplementation, lifestyle modification, or physician-guided treatment. Retest at 8-12 weeks to verify response.
Greg, three months after finding a functional medicine physician who re-ran his labs with a different interpretive framework, had iron supplementation, thyroid treatment with selenium and gluten elimination addressing his Hashimoto’s, vitamin D optimization, and a clear picture of why he’d been symptomatic for years while being told he was fine. His energy returned over about ten weeks — not overnight, not completely, but enough that he recognized himself again. Not everyone’s “normal” labs hide the same story his did. But understanding the difference between a statistical reference range and an optimal functional range is the prerequisite for getting from “your labs look fine” to “here’s what’s actually going on and what we can do about it.”
Common Questions About Blood Test Results
- Why do doctors use standard ranges instead of optimal ranges?
Standard medicine orients toward diagnosing disease in populations and providing cost-effective standardized care. The reference ranges are calibrated to flag pathology that requires treatment — not to identify the spectrum between “not sick” and “optimally functioning.” Most physicians train in disease management, not health optimization, and work under time and system constraints that make individualized optimization difficult. The financial structure of medicine rewards disease treatment more than disease prevention and functional optimization. Functional and preventive medicine practitioners take a different approach, but they’re a minority of clinical practice. - Is my vitamin D level of 35 ng/mL actually low?
By standard lab criteria, 35 ng/mL is “sufficient.” By optimal range criteria based on outcome research, it’s below the 40-60 ng/mL range associated with best immune function, bone density, muscle performance, and potentially cardiovascular and cancer risk reduction. Whether it’s meaningfully affecting function depends on context, but from an optimization standpoint, 35 ng/mL leaves real room for improvement. Supplemental D3 with K2 alongside it typically moves levels into the 45-60 ng/mL zone within 8-12 weeks, though how much that takes depends on body weight and baseline — which is why the follow-up test matters more than the figure you start with. - What’s the most important lab marker that’s routinely missed?
Fasting insulin is probably the single most informative missed marker for long-term metabolic health. It gives 5-15 years of early warning on developing insulin resistance before blood glucose goes abnormal. Cheap to test and rarely ordered in standard annual checkups. Add fasting insulin to any comprehensive panel regardless of whether a physician spontaneously orders it. Lp(a) is a close second — genetically determined, missed by all standard lipid panels, and affects 20% of the population at levels that substantially elevate cardiovascular risk. - Can I interpret my own lab results using optimal ranges?
Yes, with limitations. The optimal ranges here draw on published research and functional medicine consensus. Applying them gives a different perspective than standard lab interpretation. But optimal ranges aren’t diagnostic — symptoms, clinical context, and multiple biomarkers together carry more information than any single number. Significant deviations from optimal ranges warrant a conversation with a clinician, not self-treatment. The goal of self-education is more informed conversations with practitioners, not replacing clinical judgment. - My ferritin is 22 ng/mL and my doctor says it’s fine. Should I supplement iron?
Not without clinical guidance. Iron supplementation without confirmed deficiency can cause iron overload in susceptible individuals, which does more damage than iron deficiency. That said, a ferritin of 22 ng/mL sits below the functional optimal of 70-150 ng/mL for men (40-100 for women) and may be contributing to fatigue or cognitive symptoms. The right next step is discussing it with a physician oriented toward functional ranges. Before supplementing, it matters to understand why ferritin is low — inadequate dietary iron, impaired absorption, blood loss — and to rule out hemochromatosis, a genetic iron overload condition that paradoxically presents with low transferrin saturation and normal ferritin in early stages. - What’s the best way to get labs tested against optimal ranges?
Options include: functional medicine physicians who order comprehensive panels and interpret against optimal ranges; direct-to-consumer lab services (Ulta Lab Tests, LabCorp Direct, Function Health, Everly Well) where results can be ordered directly and interpreted using this framework; and conventional physicians open to discussing optimal interpretation when patients bring the research. Function Health’s comprehensive annual panel covering 100+ biomarkers is one of the more thorough direct-to-consumer options. Marek Health and similar services pair direct lab ordering with functional medicine-oriented medical oversight. - How often should I retest?
For a baseline comprehensive panel: annually, at minimum. More frequently while actively addressing specific markers — retest anything actively being treated (iron, vitamin D, insulin) at 8-12 weeks to verify response. For TSH and thyroid markers during treatment: every 6-8 weeks until stable, then every 6 months. For ApoB and lipid markers: annually once stable, or 6-8 weeks after any dietary or medication change. For Lp(a): once is usually sufficient — genetically determined, doesn’t change meaningfully with lifestyle.
The gap between “normal” and “optimal” is where most functional health optimization lives. Standard reference ranges tell you whether you’ve crossed into diagnosable disease. Optimal ranges tell you whether you’re in the zone where you’ll feel, function, and age best. Understanding these as different questions with different answers is the first step toward getting blood work that actually answers what’s being asked. The optimal range framework offers a starting point — not a replacement for clinical judgment, but a more useful interpretive lens than statistical normal ranges built on populations that include the chronically unwell.
The data to explain Greg’s symptoms sat in his blood the entire time. Three physicians looked at those numbers and saw “normal.” A fourth looked at the same numbers, applied a different standard, ordered the comprehensive thyroid panel the TSH alone couldn’t justify, and built him a protocol that addressed what was actually there. Same biology. Same numbers. Completely different interpretive framework. Completely different outcome. That difference is what this is about.
Related reading: Functional Health Hub
References
Editorial StandardsCorrectionsMedical DisclaimerAbout Our ContentAffiliate DisclosureSite Map